{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:01:25Z","timestamp":1756771285235,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014039","name":"US Department of Defense Prostate Cancer Research Program","doi-asserted-by":"publisher","award":["W81XWH-18-2-0040"],"award-info":[{"award-number":["W81XWH-18-2-0040"]}],"id":[{"id":"10.13039\/100014039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.virol.2024.110158","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T02:28:55Z","timestamp":1718936935000},"page":"110158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1"],"prefix":"10.1016","volume":"597","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2900-1667","authenticated-orcid":false,"given":"Jiae","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousman","family":"Jobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supachai","family":"Rerks-Ngarm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Punnee","family":"Pitisuttithum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorachai","family":"Nitayaphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Ake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venigalla B.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-4969","authenticated-orcid":false,"given":"Mangala","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.virol.2024.110158_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ni1566","article-title":"HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells","volume":"9","author":"Arthos","year":"2008","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.virol.2024.110158_bib2","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1128\/jvi.71.5.3932-3939.1997","article-title":"Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection","volume":"71","author":"Chackerian","year":"1997","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2024.110158_bib3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.tim.2019.06.002","article-title":"Molecular mechanism of HIV-1 entry","volume":"27","author":"Chen","year":"2019","journal-title":"Trends Microbiol."},{"issue":"18","key":"10.1016\/j.virol.2024.110158_bib4","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1128\/JVI.00984-13","article-title":"Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains","volume":"87","author":"Chuang","year":"2013","journal-title":"J. Virol."},{"issue":"228","key":"10.1016\/j.virol.2024.110158_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.virol.2024.110158_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition","volume":"384","author":"Corey","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.virol.2024.110158_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006182","article-title":"Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial","volume":"13","author":"Easterhoff","year":"2017","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.virol.2024.110158_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131437","article-title":"HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions","volume":"5","author":"Easterhoff","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.virol.2024.110158_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"Falkowska","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.virol.2024.110158_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/COH.0b013e328363a90e","article-title":"Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site","volume":"8","author":"Georgiev","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"14","key":"10.1016\/j.virol.2024.110158_bib11","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7424","key":"10.1016\/j.virol.2024.110158_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"issue":"7525","key":"10.1016\/j.virol.2024.110158_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface","volume":"515","author":"Huang","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.virol.2024.110158_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2012.04.017","article-title":"An anti-phosphoinositide-specific monoclonal antibody that neutralizes HIV-1 infection of human monocyte-derived macrophages","volume":"430","author":"Jobe","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.virol.2024.110158_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.virol.2017.05.015","article-title":"Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies","volume":"508","author":"Kim","year":"2017","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2024.110158_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040782","article-title":"Primary HIV-1 and infectious molecular clones are differentially susceptible to broadly neutralizing antibodies","volume":"8","author":"Kim","year":"2020","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.virol.2024.110158_bib17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1462-5822.2012.01812.x","article-title":"The molecular basis of HIV entry","volume":"14","author":"Klasse","year":"2012","journal-title":"Cell Microbiol."},{"issue":"6623","key":"10.1016\/j.virol.2024.110158_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.add6502","article-title":"Vaccination induces HIV broadly neutralizing antibody precursors in humans","volume":"378","author":"Leggat","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.virol.2024.110158_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2012.11.011","article-title":"Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"issue":"7446","key":"10.1016\/j.virol.2024.110158_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.virol.2024.110158_bib21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nbt.3187","article-title":"COMPASS identifies T-cell subsets correlated with clinical outcomes","volume":"33","author":"Lin","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"6303","key":"10.1016\/j.virol.2024.110158_bib22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1126\/science.aag0491","article-title":"Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus","volume":"353","author":"Liu","year":"2016","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.virol.2024.110158_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88522","article-title":"Tissue memory B cell repertoire analysis after ALVAC\/AIDSVAX B\/E gp120 immunization of rhesus macaques","volume":"1","author":"Luo","year":"2016","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.virol.2024.110158_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143895","article-title":"Identification of new regions in HIV-1 gp120 variable 2 and 3 loops that bind to alpha4beta7 integrin receptor","volume":"10","author":"Peachman","year":"2015","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.virol.2024.110158_bib25","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.virol.2024.110158_bib26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/infdis\/jix099","article-title":"Randomized, double-blind evaluation of late boost strategies for HIV-uninfected vaccine recipients in the RV144 HIV vaccine efficacy trial","volume":"215","author":"Rerks-Ngarm","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virol.2024.110158_bib27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1473-3099(12)70088-9","article-title":"Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B\/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144","volume":"12","author":"Robb","year":"2012","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.virol.2024.110158_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108446","article-title":"Cryptic determinant of alpha4beta7 binding in the V2 loop of HIV-1 gp120","volume":"9","author":"Tassaneetrithep","year":"2014","journal-title":"PLoS One"},{"year":"2023","series-title":"UNAIDS Data 2023","key":"10.1016\/j.virol.2024.110158_bib29"},{"issue":"5950","key":"10.1016\/j.virol.2024.110158_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"issue":"7365","key":"10.1016\/j.virol.2024.110158_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.virol.2024.110158_bib32","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5993","key":"10.1016\/j.virol.2024.110158_bib33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.virol.2024.110158_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053629","article-title":"Analysis of V2 antibody responses induced in vaccinees in the ALVAC\/AIDSVAX HIV-1 vaccine efficacy trial","volume":"8","author":"Zolla-Pazner","year":"2013","journal-title":"PLoS One"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268222400179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268222400179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T08:46:20Z","timestamp":1756716380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268222400179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"alternative-id":["S004268222400179X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110158","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110158"}}